A B S T R A C T Recent observations indicate that in thyroparathyroidectomized (TPTX) rats fed a low (0.2 gll00 g) phosphorus diet, the tubular phosphaturic response to parathyroid hormone (PTH) 
INTRODUCTION
Restriction in the supply of dietary inorganic phosphate (Pi)' has been shown to blunt the acute tubular phosphaturic response to parathyroid hormone (PTH) in dogs (1) . The same phenomenon was later observed in thyroparathyroidectomized (TPTX) rats (2, 3) . Although the nature ofthis phenomenon remains obscure, it may be related to the fact that phosphate deprivation enhances the tubular capacity of the kidney to reabsorb Pi in TPTX rats (4, 5) .
Recently, clearance studies have shown that chronic administration of small doses of 1,25-dihydroxyvitamin D3 [1, 25(OH) 2D3] to TPTX rats hinders the effect of phosphate deprivation on the overall tubular Pi transport capacity (6) .
In the present work, we have investigated whether chronic administration of 1,25(OH)2D3 could prevent the blunting of the phosphaturic response to PTH in phosphate-deprived TPTX rats. Because preliminary studies indicated that in our experimental conditions phosphate depletion also reduced the caleemic effect 1Abbreviations used in this paper: cAMP, cyclic-3',5'-AMP; [Ca] pl, plasma Ca concentration; FEPi, fractional excretion of inorganic phosphate; GFU, glomerular filtration rate; HPD, high phosphorus diet; LPD, low phosphorus diet; 1,25 (OH)2D3, 1,25-dihydroxyvitamin D3; 25(OH)D3, 25-hydroxyvitamin D3; Pi, inorganic phosphate; [Pi] pl, plasma Pi concentration; PTH, parathyroid hormone; TPTX, thyroparathyroidectomized; UrcaV, urinary Ca exeretion; Ur,AMPV, urinary cANIP excretion; UrNaV, urinary Na excretion; UrNV, urinary Pi exeretion; UrV, urinary excretion.
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METHODS
Preparation of the animals. Male Wistar rats that weighed 160-180 g, raised on a commercial chow (Altromin 1314, Altrogge, Lage, Lippe, West Germany) containing 1.2 g/100 g phosphorus (P), 1.1 g/100 g calcium (Ca), and 180 IU/100 g vitamin D3, were selected for the study. 7 d before the renal study, the animals were pair-fed low (0.2 g/100 g) and high (1.2 g/100 g) P diets prepared as previously described (6) . Ca content was 1.1 g/100 g in both diets. During this period, and in the first series of experiments, one group of rats fed the low P diet (LPD) received 1,25(OH)2D3 intraperitoneally at the dose of 13 pmol/25 ,ul ethanol twice daily. The last injection of 1,25(OH)2D3 was administered 1 h before the renal study. The other two groups of animals fed either a LPD or high P diet (HPD) received intraperitoneal injections of the ethanol vehicle. In a second series of experiments, the influence of 25-hydroxyvitamin D3 [25(0H)D3] was compared with that of 1,25(OH)2D3 in rats fed LPD. 25(OH)D3 was given intraperitoneally in doses of 13, 130, 1,300, and 13,000 pmol/25 ,ul ethanol twice daily. In a third series of experiments, the chronic influence of 1,25(OH)2D3, administered as mentioned above, on the tubular phosphaturic response to parathyroid hormone in rats fed the 0.2-g/100 g P diet was compared with the effect of raising the P content of the diet from 0.2 to 0.3 gIlOO g. This latter diet was selected because it provided a basal level of plasma Pi similar to that observed in the 1,25(OH)2D3-treated animals fed the 0.2-g/100 g P diet.
2 d before the renal study, all rats were TPTX as previously reported (6) . The food was withdrawn 24 h before starting the clearance measurements.
Clearance experiments. The general methodology of the clearance measurement in conscious rats has been described earlier (4, 6) . In the present study, the experiments were started between 9 
RESULTS
Phosphaturic response. As expected, the phosphaturic response to PTH was markedly influenced by the phosphate intake of the animals (Table I, Fig. 1 ) Indeed, the imean (±SEM) rise in the fractional excretion of Pi (FEPi) was 10 times larger in the rats fed HPD as comiipared with that observed in the LPD group (HPD: AFEPi = +0.216+0.018, n = 8; LPD: AFEPi = +0.019±0.006, n = 8, P < 0.001) (Fig. 1 ).
The chronic administration of 1,25(OH)2D3 (2 x 13 pmol/d i.p. for 7 d) to LPD rats had a striking influence on the phosphaturic response to PTH. As illustrated in Fig. 1 (Table I) . Therefore, the 1,25(OH)2D3-induced enhancement of the phosphaturic response to PTH could be related to the increased phosphatemia recorded during basal coInditions. Feeding rats a 0.3-instead of a 0.2-g/100 g P diet increased the base-line [Pin to the level observed in the 1,25(OH)2D3-treated animals. This regimen (0.3 g/100 g P) elicited a larger phosphaturic response than that observed in a group of rats pair-fed with a 0.2-g/100 g P diet (Table II) . This response remained, however, significantly (P < 0.001) smaller than that monitored in the 1,25(OH)2D3-treated animals pair-fed with the 0.2-g/100 g P diet.
cAMP response. As shown in Table I +0.57±0.05 mM). After discontinuing the PTH administration, the rise in plasma Ca was maintained both in HPD (A control 2 -1 = +0.35±0.06 mM) and in LPD plus 1,25(OH)2D3 (A control 2 -1 = +0.63+0.06 mM). In contrast, the small calcemic response observed in LPD rats without 1,25(OH)2D3 treatment rapidly disappeared after stopping the PTH infusion (A control 2 -1 = +0.01±0.07 mM). Thus, although the magnitude and the duration of PTH-induced reduction in UrcaV/ml GFR were similar in both LPD groups, a substantial and prolonged rise in plasma Ca was observed solely in the animals pretreated with 1,25-(OH)2D3.
GFR, urinary Na excretion (UrNaV), and urine pH.
The modulation of the phosphaturic response to PTH by dietary Pi or 1,25(OH)2D3 was not associated with alteration in GFR (Table I) .
No difference in UrNaV/ml GFR was found between the three groups during control 1. The rise in urinary Pi excretion (Up1V) observed in the HPD and LPD groups treated with 1,25(OH)2D3 was associated with a parallel increase in UrNaV/ml GFR. In the latter two groups, the increase in the amount of pmoles of sodium excreted under PTH was <1.5-fold that of phosphate. Therefore, the increase in sodium excretion certainly did not exceed the amount required for maintaining the electroneutrality of urine. After cessation of the PTH infusion, and increase in UrNaV/ml GFR was noted in all three experimental groups. Such a rise probably resulted from a progressive expansion of the extracellular volume as a result of the constant infusion of isotonic saline.
Finally 
DISCUSSION
The present study indicates that phosphate deprivation does not blunt the acute phosphaturic response to PTH when rats are chronically supplemented with small doses of 1,25(OH)2D3. The marked enhancement of the phosphaturic response to PTH in the 1,25(OH)2D3-treated animals cannot be ascribed to an elevation in the plasma concentration and(or) filtered load of Pi at the time the tubular effect of the peptide hormone was recorded. It is unlikely that the slightly higher initial plasma Pi level observed after 1,25(OH)2D3 treatment in LPD rats could in itself account for the dramatic increase in the phosphaturic response to PTH. Indeed, a previous study (7) has shown that the phosphaturic response to PTH in phosphate-depleted TPTX rats remains conspicuously blunted during a Pi infusion, which acutely increased the plasma Pi to the level observed in phosphate-replete TPTX counterparts. It is, however, conceivable that 1,25(OH)2D3 given during phosphate restriction prevented the renal resistance to the phosphaturic action of PTH by its longterm action on Pi metabolism (8) . The small increase in the basal plasma Pi level observed after 1,25(OH)2D3 treatment in LPD rats may in fact reflect such a longterm alteration in Pi metabolism. When a similar elevation in the basal plasma Pi level was achieved by providing more Pi in the diet (Table II) , an enhancement in the phosphaturic response to PTH was also observed. However, the magnitude of the response remained significantly inferior to that recorded after (6) . The data reported in the present work raises the question of whether or not the powerful effect of 1,25-(OH)2D3 on the phosphaturic response to PTH when given at the dose of 13 pmol twice daily has a physiological relevance. From previous studies (9) (10) (11) , evidence has been obtained that the same amount of 1,25(OH)2D3 administered to TPTX rats fed a HPD can be considered a substitution dose for the reduced endogenous production of the metabolite that follows the removal of the parathyroid glands (12, 13) . However, the same consideration cannot be applied when these doses of 1,25(OH)2D3 are given to TPTX rats fed a LPD. Indeed, in these animals the production (14) and the plasma level (13) (16) .
Our experiments do not permit us to understand the mechanism whereby 1,25(OH)2D3 influences the phosphaturic response to PTH. It is difficult to believe that the effect of 1,25(OH)2D3 might be related to the influence of the metabolite on plasma calciuim (17) . In the present work, 1,25(OH)2D3 did not increase the level of plasma Ca as determined before the PTH inftusion (Table I) . However, during the administration of the peptide hormone, plasma Ca rose significantly in phosphate-depleted rats that were treated with 1,25(OH)2D3. It has been suggested (18) that an acute elevation in plasma Ca may potentiate the phosphaturic respon.se to PTH in TPTX dogs. However, this effect has not been observed in parathvroidectomized rats (19) . Furthermore, acute calcium infusion has been shown to decrease rather than to increase FEPi in parathyroidectomized rats (20) . Therefore, it appears unlikely that the elevation in plasma Ca during PTH infusion is the main factor responsible for the enhanced phosphaturia that we have observed in the 1,25(OH)2D3-treated rats.
In our experiments, the elevation of plasma Ca in response to PTH was somewhat blunted after phosphate deprivation. To our knowledge such an influence of the dietary phosphate supply on the calcemic effect of PTH has not yet been reported. Interestingly, an enhanced calcemic response to the peptide hormone can be observed when phosphate-depleted TPTX rats are treated with 1,25(OH)2D3. The rise in the calcemia does not seem to be of intestinal or renal origin. The animals were fasted overnight, and the increase in the tubular reabsorption of calcium was similar whether or not they had received the 1,25(OH)2D3 treatment. It is more likely that the elevation in the calcemia during and immediately after PTH infusion results from a greater mobilization of calcium from bone in the animals supplemented with 1,25(OH)2D3. The fact that the calcemic response was maintained after discontinuing the infusion of PTH and after the disappearance of its hypocalciuric effect sustains this assertion. It has been known for several years that in vitamin D-deficient animals the skeleton is resistant to the Ca-mobilizing action of PTH (21, 22) . More recently, evidence has been presented indicating that the PTH-induced mobilization of calcium from bone requires the presence of 1,25(OH)2D3 to be fully expressed (23) . Other evidence along this line has been obtained by Massry et al. (24) , who showed that in uremic dogs, 1,25(OH)2D3 administration partially restores the blunted calcemic response to PTH. Finally, in patients with pseudohypoparathyroidism, 1,25(OH)2D3 has been shown to normalize the impaired calcemic response to PTH (16, 25) , a phenomenon which had previously been observed with pharmacological doses of vitamin D (26, 27) .
Thus, in addition to phosphate-depleted animals, in several experimental and pathological situations where the phosphaturic and(or) calcemic response to PTH is impaired, 1,25(OH)2D3 has the ability to normalize this response. The relation between these situations and phosphate depletion is not at all apparent at this stage of our knowledge. More information about the basic mechanisms regulating the translocation of Pi and Ca at the kidney and bone levels is needed before the nature of the interrelationship between the action ofPTH and 1,25(OH)2D3 on these processes can be fully appreciated.
